SCOTT NAPLES: Open Payments
NPI 1942627708 · FPO, AP. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 9 payments from 7 companies in 2025. Trend: 2023 $14 · 2024 $113 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| CSL Behring | 2 | $55 |
| PFIZER INC. | 2 | $42 |
| UCB, Inc. | 1 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $27 |
| Boston Scientific Corporation | 1 | $17 |
Products named: AUSTEDO XR, Kcentra, ELIQUIS, Fintepla, ULTOMIRIS, XIFAXAN, WATCHMAN FLX.
Industry payments across AP — which companies pay providers there.
